Nicole Sweeny Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

KALV Quotes by TradingView

Nicole Sweeny is Chief Commercial Officer of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 32,291 shares of KALV, which is worth approximately $395,564. The most recent transaction as insider was on Aug 25, 2025, when has been sold 1,480 shares (Common Stock) at a price of $13.42 per share, resulting in proceeds of $19,861. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.3K
n/a 3M change
n/a 12M change
Total Value Held $395,564

Nicole Sweeny Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 25 2025
SELL
Open market or private sale
$19,861 $13.42 p/Share
1,480 Reduced 4.38%
32,291 Common Stock
Aug 22 2025
SELL
Open market or private sale
$24,642 $13.22 p/Share
1,864 Reduced 6.08%
28,771 Common Stock
Aug 22 2025
BUY
Exercise of conversion of derivative security
-
5,000 Added 12.9%
33,771 Common Stock
Aug 21 2025
BUY
Exercise of conversion of derivative security
-
6,250 Added 16.94%
30,635 Common Stock

Also insider at

PRAX
Praxis Precision Medicines, Inc. Healthcare
Chief Commercial Officer
NS

Nicole Sweeny

Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KALV